FindTrial
Sign In

Study on the prevalence of hyperuricemia and related risk factors in Shanghai residents

Study on the prevalence of hyperuricemia and related risk factors in Shanghai residents

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033315
Enrollment
Unknown
Registered
2020-05-27
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperuricemia

Interventions

male vs female:Nil

Sponsors

Shanghai East Hospital Affiliated to Tongji University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 98 Years

Inclusion criteria

Inclusion criteria: Residents in Shanghai who are at least 18 years old.

Exclusion criteria

Exclusion criteria: Those with tumors and autoimmune diseases or undergoing other clinical trials.

Design outcomes

Primary

MeasureTime frame
serum uric acid;—

Countries

China

Contacts

Public ContactNa Liu

Tongji University

naliubrown@163.com+86 18217768587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026